The Cooper Companies, Inc. (COO) Average Earnings Yield
The current earnings yield for The Cooper Companies, Inc. (COO) is 1.74% as of Sunday, June 14, 2026, shown against its trailing averages.
Average Earnings Yield Chart
COO Earnings Yield Averages
EARNINGS YIELD CURRENT
1.74%
EARNINGS YIELD TTM
2.75%
EARNINGS YIELD 3Y
2.25%
EARNINGS YIELD 5Y
12.73%
EARNINGS YIELD 10Y
12.04%
EARNINGS YIELD 15Y
13.63%
EARNINGS YIELD 20Y
14.17%
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White